20x LWD Objectives for deFonbrune Systems

Enzyme Immunoassay for the Quantitative Measurement of Ovarian Cancer Antigen CA-125 in Human Serum...

Abbott offers an array of both in-vitro and molecular diagnostic tests for the detection and monitoring of cancerous conditions in patients....

... BrainSUITE iMRI is a neurosurgical OR ... and diagnostic tools, including iMRI, necessary ... BrainSUITE iMRI, neurosurgical treatments are performed ... and designed for MR compatibility and ...

... Quality EEG recording is assured even ... Neurofax has high performance, high sensitivity ... ECG rejection filter, shielded electrodes and a ... connection. Neurofax is a complete and ...

(Date:12/16/2009)... essential fatty acids commonly found in fatty fish ... to research published by the American Psychological Association. ... problems found in people with schizophrenia; bipolar, obsessive-compulsive, ... afflictions of the nervous system. , The ... , provides more evidence that fish is brain ...

(Date:12/16/2009)... cut bleeding time in half, but use in humans is ... Hoping to improve on nature, researchers have built and tested ... used in trauma or other cases where blood just won,t ... material that is used in degradable stitches, which dissolve in ... engineering at Case Western Reserve University, and lead author of ...

(Date:12/16/2009)... Neurological Stress Reduction Therapy or NSRTSM is found very effective ... such as allergies, asthma, migraines, chronic fatigue and a wide ... the country are using this holistic therapy including over 50 ... ... Minneapolis, MN (Vocus) December 14, 2009 -- BioVeda ...

(Date:12/16/2009)... government report finds , , WEDNESDAY, Dec. 16 (HealthDay News) ... 45.4 million Americans of all ages -- or 15.1 ... according to new National Health Interview Survey statistics released ... of all ages had been uninsured for at least ... 31.9 million (10.6 percent) had been uninsured for more ...

(Date:12/16/2009)... Dec. 16 OrthoAccel Technologies, Inc., developers ... an acceleration device to enhance orthodontics, announced Alison ... the UK. Ms. Davies has spent the ... the dental industry, most recently for nine years ... , makers of Invisalign . ...

... Accelerate Manufacture of Clinical Trial ... Pharmaceuticals, ... Michigan company specializing in winning FDA approval,for new drugs and medical ... award. RAA received the award for its development,of a fast-track process ...

... NATICK, Mass., Oct. 17 Boston Scientific,Corporation ... initiatives designed to,enhance short- and long-term shareholder value, ... as well as substantial expense and head,count reductions ... The,Company also said it is making good progress ...

... Oct. 17 GenPrime, Inc. a leading,provider of ... of its Bacterial Contamination Test for Platelets(TM). The,test ... presence of aerobic and,anaerobic bacteria commonly found in ... a 510 (K) pre-market notification with the Food,and ...

... ,Haemonetics Corporation (NYSE: HAE ) is pleased ... effective October 22, 2007 as President,Haemonetics Japan. Ms. ... who previously announced plans to retire. Brian ... tremendous experience and a proven track record for ...

... Address FDA,s Next Big Challenge, WASHINGTON, Oct. 17 ... information on drugs,and devices to physicians and the public?, ... will discuss and debate at a,landmark Colloquium, Communicating Risk/Safety ... Food and Drug Law Institute (FDLI),Dec. 6, 2007, in ...

... Kyphon Inc.,(Nasdaq: KYPH ) today announced ... and the Foundation for Osteoporosis Research,and Education (FORE) ... during World Osteoporosis Day on Saturday, October 20, ... go to: http://www.prnewswire.com/mnr/kyphon/29938/ To ...

(Date:12/16/2009)... ALTO, Calif., Dec. 16 The Boards ... Corporation are delighted to announce the merger of ... the field of RNAi (RNA interference). The ... have multiple RNAi discovery, development and delivery technologies, ... a broad portfolio of intellectual property. ,, ...

(Date:12/16/2009)... 16 ChemoCentryx, Inc. today announced that ... 2 clinical trial of CCX354, an orally-bioavailable, novel, ... CCR1 chemokine receptor for the treatment of rheumatoid ... potent and selective antagonist of CCR1, a chemokine ... such as monocytes and macrophages, associated with the ...

(Date:12/15/2009)... ARDEE, Ireland, Dec. 15 Warner Chilcott ... its subsidiary Warner Chilcott Corporation (the "Company") has ... and subject to the conditions set forth in ... Statement dated December 15, 2009 (the "Offer to ... 8.75% senior subordinated notes due 2015 (the "Notes"). ...